These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23199962)

  • 41. The current and future role of screening in the era of HPV vaccination.
    Myers E; Huh WK; Wright JD; Smith JS
    Gynecol Oncol; 2008 May; 109(2 Suppl):S31-9. PubMed ID: 18482556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus vaccines: who will pay, who will receive, when to administer?
    Saslow D; Wheeler CM
    Ethn Dis; 2007; 17(2 Suppl 2):S2-8-13. PubMed ID: 17684807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries.
    Sancho-Garnier H; Khazraji YC; Cherif MH; Mahnane A; Hsairi M; El Shalakamy A; Osgul N; Tuncer M; Jumaan AO; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G51-7. PubMed ID: 24331820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review.
    Elfström KM; Herweijer E; Sundström K; Arnheim-Dahlström L
    Curr Opin Oncol; 2014 Jan; 26(1):120-9. PubMed ID: 24248011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
    Schejter E; Bornstein J; Siegler E
    Vaccine; 2013 Nov; 31 Suppl 8():I42-5. PubMed ID: 24229718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV vaccination: the promise & problems.
    Sankaranarayanan R
    Indian J Med Res; 2009 Sep; 130(3):322-6. PubMed ID: 19901441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
    Luciani S; Jauregui B; Kieny C; Andrus JK
    Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
    Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
    Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries.
    Bello FA; Enabor OO; Adewole IF
    Afr J Reprod Health; 2011 Mar; 15(1):25-30. PubMed ID: 21987934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer].
    Boeke AJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):981-3. PubMed ID: 18549170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
    Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
    Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospects and challenges in the introduction of human papillomavirus vaccines in the extended Middle East and North Africa region.
    Jumaan AO; Ghanem S; Taher J; Braikat M; Al Awaidy S; Dbaibo GS
    Vaccine; 2013 Dec; 31 Suppl 6():G58-64. PubMed ID: 24331821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
    Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
    BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What works for human papillomavirus vaccine introduction in low and middle-income countries?
    Howard N; Gallagher KE; Mounier-Jack S; Burchett HED; Kabakama S; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():22-25. PubMed ID: 29179865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States.
    Castle PE; Solomon D; Saslow D; Schiffman M
    Cancer; 2008 Nov; 113(10 Suppl):3031-5. PubMed ID: 18980285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.